Neuroleptic malignant syndrome in COVID-19 patients by Soh et al.

Ubhayakar, Nitin; Liu, Antonio

Ubhayakar, Nitin; Liu, Antonio.

Ubhayakar N; Adventist Health White Memorial, Los Angeles, CA, United States of America.
Liu A; Adventist Health White Memorial, Los Angeles, CA, United States of America. Electronic address: anthonyseanliu@yahoo.com.

Am J Emerg Med ; 43: 259, 2021 05.

Article in English | MEDLINE | ID: covidwho-1326882

Subject(s)

Antipsychotic Agents; COVID-19; Neuroleptic Malignant Syndrome; Antipsychotic Agents/adverse effects; Humans; Neuroleptic Malignant Syndrome/diagnosis; Neuroleptic Malignant Syndrome/etiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / COVID-19 / Neuroleptic Malignant Syndrome Type of study: Diagnostic study Limits: Humans Language: English Journal: Am J Emerg Med Year: 2021 Document Type: Article Affiliation country: J.ajem.2020.06.038

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google